DK3201317T3 - BIOMARKETORS FOR RHEUMATOID ARTHRITIS AND USE THEREOF - Google Patents

BIOMARKETORS FOR RHEUMATOID ARTHRITIS AND USE THEREOF Download PDF

Info

Publication number
DK3201317T3
DK3201317T3 DK15847187.0T DK15847187T DK3201317T3 DK 3201317 T3 DK3201317 T3 DK 3201317T3 DK 15847187 T DK15847187 T DK 15847187T DK 3201317 T3 DK3201317 T3 DK 3201317T3
Authority
DK
Denmark
Prior art keywords
biomarketors
rheumatoid arthritis
rheumatoid
arthritis
Prior art date
Application number
DK15847187.0T
Other languages
Danish (da)
Inventor
Qiang Feng
Dongya Zhang
Huijue Jia
Donghui Wang
Jun Wang
Original Assignee
Bgi Shenzhen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CN2014/088069 external-priority patent/WO2016049937A1/en
Priority claimed from PCT/CN2014/088068 external-priority patent/WO2016049936A1/en
Priority claimed from PCT/CN2014/088060 external-priority patent/WO2016049930A1/en
Application filed by Bgi Shenzhen filed Critical Bgi Shenzhen
Application granted granted Critical
Publication of DK3201317T3 publication Critical patent/DK3201317T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
DK15847187.0T 2014-09-30 2015-07-07 BIOMARKETORS FOR RHEUMATOID ARTHRITIS AND USE THEREOF DK3201317T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/CN2014/088069 WO2016049937A1 (en) 2014-09-30 2014-09-30 Biomarkers for rheumatoid arthritis and usage therof
PCT/CN2014/088068 WO2016049936A1 (en) 2014-09-30 2014-09-30 Biomarkers for rheumatoid arthritis and usage therof
PCT/CN2014/088060 WO2016049930A1 (en) 2014-09-30 2014-09-30 Biomarkers for rheumatoid arthritis and usage therof
PCT/CN2015/083488 WO2016050110A1 (en) 2014-09-30 2015-07-07 Biomarkers for rheumatoid arthritis and usage thereof

Publications (1)

Publication Number Publication Date
DK3201317T3 true DK3201317T3 (en) 2020-01-20

Family

ID=55629412

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15847187.0T DK3201317T3 (en) 2014-09-30 2015-07-07 BIOMARKETORS FOR RHEUMATOID ARTHRITIS AND USE THEREOF

Country Status (11)

Country Link
US (1) US10883146B2 (en)
EP (1) EP3201317B1 (en)
JP (1) JP6485843B2 (en)
KR (1) KR101986442B1 (en)
CN (2) CN108064263B (en)
AU (1) AU2015327511B2 (en)
CA (1) CA2963013C (en)
DK (1) DK3201317T3 (en)
HK (2) HK1248764A1 (en)
RU (1) RU2691375C2 (en)
WO (2) WO2016050110A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11514289B1 (en) * 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
WO2019071516A1 (en) * 2017-10-12 2019-04-18 Perfect (China) Co., Ltd. Biomarkers for chronic hepatitis b and use thereof
CN108034708B (en) * 2017-12-14 2020-05-22 中国中医科学院中药研究所 System for determining individual effectiveness of tripterygium glycosides tablet in treating rheumatoid arthritis through expression quantity of multiple mRNA
CN109065168B (en) * 2018-08-29 2021-09-14 昆明理工大学 Method for evaluating disease risk based on spatio-temporal clustering statistics
CN111161794B (en) * 2018-12-30 2024-03-22 深圳碳云智能数字生命健康管理有限公司 Intestinal microorganism sequencing data processing method, device, storage medium and processor
CN111161795A (en) * 2019-01-15 2020-05-15 深圳碳云智能数字生命健康管理有限公司 Intestinal microorganism sequencing data processing method and device, storage medium and processor
JP2021010343A (en) * 2019-07-08 2021-02-04 三菱ケミカル株式会社 Health condition prediction method by oral cavity bacteria
CN113488107B (en) * 2021-07-07 2022-07-19 广州华银康医疗集团股份有限公司 Method, apparatus and storage medium for screening immunohistochemical library sequencing biomarkers
CN114369671A (en) * 2021-11-25 2022-04-19 上海锐翌生物科技有限公司 Marker microorganism for rheumatic arthritis and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030274A1 (en) * 2001-07-26 2003-05-08 Alimentary Health Ltd LACTOBACILLUS SALIVARIUS STRAINS
RU2362808C1 (en) * 2008-02-13 2009-07-27 Государственное образовательное учреждение дополнительного профессионального образования Российская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию (ГОУ ДПО РМАПО Росздрава) Way of diagnostics of microbiota disbalance of various human biotopes and degree of its expression
CN101886132B (en) * 2009-07-15 2013-09-18 北京百迈客生物科技有限公司 Method for screening molecular markers correlative with properties based on sequencing technique and BSA (Bulked Segregant Analysis) technique
CN101921748B (en) * 2010-06-30 2012-11-14 上海华大基因科技有限公司 DNA molecular label for high-throughput detection of human papilloma virus
RU2014123511A (en) * 2011-11-10 2015-12-20 Дженентек, Инк METHODS FOR TREATING, DIAGNOSTIC AND MONITORING ALZHEIMER'S DISEASE
JP5863035B2 (en) * 2012-03-07 2016-02-16 国立大学法人 東京大学 Method for detecting inflammatory bowel disease and method for examining human salivary bacterial flora
US20150211053A1 (en) * 2012-08-01 2015-07-30 Bgi-Shenzhen Biomarkers for diabetes and usages thereof
WO2014019180A1 (en) * 2012-08-01 2014-02-06 深圳华大基因研究院 Method and system for determining biomarker in abnormal state

Also Published As

Publication number Publication date
CN108064272A (en) 2018-05-22
CN108064272B (en) 2021-07-09
US20170226565A1 (en) 2017-08-10
RU2691375C2 (en) 2019-06-11
EP3201317A1 (en) 2017-08-09
CA2963013C (en) 2022-10-04
CA2963013A1 (en) 2016-04-07
RU2017115001A3 (en) 2018-11-05
HK1248753A1 (en) 2018-10-19
HK1248764A1 (en) 2018-10-19
KR20170063879A (en) 2017-06-08
RU2017115001A (en) 2018-11-05
CN108064263B (en) 2022-04-26
KR101986442B1 (en) 2019-06-05
US10883146B2 (en) 2021-01-05
AU2015327511B2 (en) 2018-12-06
JP2017530708A (en) 2017-10-19
WO2016050110A1 (en) 2016-04-07
JP6485843B2 (en) 2019-03-20
WO2016050111A1 (en) 2016-04-07
CN108064263A (en) 2018-05-22
EP3201317B1 (en) 2019-12-11
EP3201317A4 (en) 2017-08-09
AU2015327511A1 (en) 2017-04-20

Similar Documents

Publication Publication Date Title
DK3333191T3 (en) Anti-C10ORF54 antibodies and uses thereof
DK3126388T3 (en) Anti-EGFRvIII antibodies and uses thereof
DK3302431T3 (en) TAXAN PARTICLES AND THEIR USE
DK3480213T3 (en) SYNTAC POLYPEPTIDES AND APPLICATIONS THEREOF
DK3215147T3 (en) NEUROTENANT NORKETAMINE COMPOUNDS AND METHODS
DK3237418T3 (en) Triazolopyrimidine Compounds and uses thereof
DK3215601T3 (en) METHODS FOR TRANSDUCTION AND CELL PROCESSING
DK3227336T3 (en) Anti-CD79b antibodies and methods for use
DK3258951T3 (en) ANTI-DIFFERENT ANTIBODIES AND PROCEDURES FOR USE
DK3149042T3 (en) PD-L1 antibodies and uses thereof
DK3155024T3 (en) RESIDENCE STRUCTURES AND RELATED PROCEDURES
DK3212255T3 (en) SELF-ORIENTATING SPRAYER AND SPRAYER INTERFACE
DK3218358T3 (en) IFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES
DK3521289T3 (en) MNK INHIBITORS AND METHODS RELATED THEREOF
DK3928818T3 (en) ATOMIZER AND CONTAINER
DK3210977T3 (en) New aminoalkylbenzothiazepine derivative and use thereof
DK3126381T4 (en) CLAUDIN-6 SPECIFIC IMMUNOR RECEPTORS AND T-CELL KEYPITOPES
DK3164774T3 (en) VESSEL HEIGHT LIMITS AND STEERING
DK3172213T3 (en) MACROCYCLIC CHINESE INHIBITORS AND USES THEREOF
DK3233221T3 (en) Training Facilities
DK3015526T3 (en) HYDROFLUOROLEFIN-BASED COMPOSITION AND USE
DK3169703T3 (en) CHIMARY ANTIGEN RECEPTOR AND ITS USE
DK3193611T3 (en) MK2 INHIBITORS AND USES THEREOF
DK3116911T3 (en) ANTI-MCAM ANTIBODIES AND RELATED PROCEDURES FOR USE
DK3101760T3 (en) CHARGING PROCEDURE AND SYSTEM